ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -17 مورد

Benzoyl peroxide and hydrocortisone: Drug information

Benzoyl peroxide and hydrocortisone: Drug information
2025© UpToDate, Inc. and its affiliates and/or licensors. All Rights Reserved.
For additional information see "Benzoyl peroxide and hydrocortisone: Patient drug information"

For abbreviations, symbols, and age group definitions show table
Brand Names: US
  • Vanoxide-HC
Pharmacologic Category
  • Acne Products;
  • Topical Skin Product;
  • Topical Skin Product, Acne
Dosing: Adult
Acne vulgaris

Acne vulgaris: Topical: Apply thin film 1 to 3 times/day.

Dosing: Kidney Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling.

Dosing: Liver Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling.

Dosing: Older Adult

Refer to adult dosing.

Dosing: Pediatric

Adolescents ≥12 years: Refer to adult dosing.

Dosing: Kidney Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer's labeling.

Dosing: Liver Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer's labeling.

Adverse Reactions

See individual agents.

Contraindications

Hypersensitivity to benzoyl peroxide, hydrocortisone, or any component of the formulation; viral diseases of the skin (eg, varicella)

Warnings/Precautions

Concerns related to adverse effects:

• Bleaching effects: May bleach hair or colored fabric.

Concurrent drug therapy issues:

• Sulfone products: Concomitant use of benzoyl peroxide with sulfone products (eg, dapsone, sulfacetamide) may cause temporary discoloration (yellow/orange) of facial hair and skin. Application of products at separate times during the day or washing off benzoyl peroxide prior to application of other products may avoid skin discoloration (Dubina 2009).

• Topical acne products: Use concomitant topical acne therapy with caution; cumulative irritancy may occur.

Other warnings/precautions:

• Appropriate use: For external use only; avoid contact with mucous membranes and eyes. Inform patients to use skin protection and minimize prolonged exposure to sun or tanning beds.

Dosage Forms: US

Excipient information presented when available (limited, particularly for generics); consult specific product labeling.

Lotion, External:

Vanoxide-HC: Benzoyl peroxide 5% and hydrocortisone 0.5% (25 g)

Generic: Benzoyl peroxide 5% and hydrocortisone 0.5% (113 g); Benzoyl peroxide 7.5% and hydrocortisone 1% (113 g)

Generic Equivalent Available: US

Yes

Pricing: US

Lotion (Benzoyl Perox-Hydrocortisone External)

5-0.5% (per gram): $19.91

Lotion (Vanoxide-HC External)

5-0.5% (per gram): $14.40

Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

Administration: Adult

Topical: Shake well prior to use. For external use only; avoid applying to inside nose, mouth, eyes, vagina, mucous membranes, and on areas of broken skin. Use caution on neck and other sensitive areas. Skin should be clean and dry before applying. Gently massage lotion to blend into skin. May bleach or stain certain fabrics; avoid contact with clothing or furniture.

Administration: Pediatric

Topical: For external use only; avoid applying to inside nose, mouth, eyes, vagina, mucous membranes, and on areas of broken skin. Shake well prior to use. Wash hand before and after use. Skin should be clean and dry before applying. Gently massage lotion to blend into skin. Use caution on neck and other sensitive areas. Avoid contact with clothing or furniture; may bleach or stain certain fabrics.

Use: Labeled Indications

Acne vulgaris: Treatment of acne vulgaris and oily skin

Medication Safety Issues
Pediatric patients: High-risk medication:

KIDs List: Medium, high, and very high potency topical corticosteroids, when used in neonates and infants <1 year of age for diaper dermatitis, are identified on the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) list; use should be avoided due to risk of adrenal suppression; systemic absorption is higher in pediatric patients than adults (strong recommendation; low quality of evidence) (PPA [Meyers 2020]).

Metabolism/Transport Effects

Refer to individual components.

Drug Interactions

Note: Interacting drugs may not be individually listed below if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed). For a complete list of drug interactions by individual drug name and detailed management recommendations, use the drug interactions program by clicking on the “Launch drug interactions program” link above.

Aminolevulinic Acid (Systemic): Photosensitizing Agents may increase photosensitizing effects of Aminolevulinic Acid (Systemic). Risk X: Avoid

Aminolevulinic Acid (Topical): Photosensitizing Agents may increase photosensitizing effects of Aminolevulinic Acid (Topical). Risk C: Monitor

Calcipotriene: Hydrocortisone (Topical) may decrease therapeutic effects of Calcipotriene. Management: Monitor for reduced calcipotriene efficacy if combined with hydrocortisone valerate. Consider separating the administration of these agents by 10 to 12 hours to minimize the risk of this potential interaction. Risk C: Monitor

Dapsone (Topical): Benzoyl Peroxide may increase adverse/toxic effects of Dapsone (Topical). Specifically, the use of these agents in combination may cause skin and facial hair to temporarily turn a tan or yellow/orange color. Risk C: Monitor

Methoxsalen (Systemic): Photosensitizing Agents may increase photosensitizing effects of Methoxsalen (Systemic). Risk C: Monitor

Porfimer: Photosensitizing Agents may increase photosensitizing effects of Porfimer. Risk X: Avoid

Verteporfin: Photosensitizing Agents may increase photosensitizing effects of Verteporfin. Risk C: Monitor

Pregnancy Considerations

Animal reproduction studies have not been conducted with this combination. See individual agents.

Breastfeeding Considerations

See individual agents.

Pharmacokinetics (Adult Data Unless Noted)

See individual agents.

  1. Benzoyl Peroxide and Hydrocortisone [prescribing information]. Las Vegas, NV: Mesora Pharma LLC; received November 2017.
  2. Dubina MI, Fleischer AB Jr. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. Arch Dermatol. 2009;145(9):1027-1029. doi:10.1001/archdermatol.2009.186. [PubMed 19770443]
  3. Meyers RS, Thackray J, Matson KL, et al. Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. J Pediatr Pharmacol Ther. 2020;25(3):175-191. [PubMed 32265601]
  4. Vanoxide HC (benzoyl peroxide and hydrocortisone) [prescribing information]. Collegeville, PA: Summers Laboratories Inc; received January 2023.
Topic 8654 Version 140.0